United Patients Group

APRIL 3, 2023

Introduction A cannabis ‘prescription’ is written by a doctor to be dispensed at a pharmacy (i.e. A recommendation from a physician is simply permission (‘recommendation’) for the patient to use cannabis, which can be obtained in any state where medical marijuana is legal.

DEA 52

DEA Patients Conditions Cannabis 52

FloridaMarijuana.net

JULY 8, 2018

5 cannabis strains to treat PTSD? The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. Medical marijuana can contribute to a patient’s overall health. 5 cannabis strains to treat PTSD: 1. Blue Dream.

Strains 190

Strains Indica Hybrid Research and Development 190

MedicalJane

JUNE 29, 2018

At the time of this article’s publishing, thirty states and the District of Columbia have enacted legislation permitting use of medical cannabis. Do you qualify for medical cannabis? There is no universal handbook for a medical cannabis program. Can your current doctor “prescribe” cannabis?

Patients 83

Patients Legalization Conditions Treatment 83

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111

DEA Hemp Cultivation Advocacy 111

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). Background.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Defining Psychedelics.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

SpeedWeed

JULY 23, 2021

This is the first time a research license for this type of work has been granted outside of state and city research licenses to study cannabis. . Thanks to the new DEA research license, MedPharm will now be able to supply investigational medications across state lines for the purpose of clinical trials.

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

CannaMD

AUGUST 8, 2020

– because today’s post is a deep dive into everything you need to know about the most popular cannabis compound around. Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol. Researchers believe cannabis contains over 100 unique chemical compounds!

CBD 100

CBD DEA Research and Development Hemp 100

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. Despite the widespread adoption, the Food and Drug Administration still classifies cannabis as a Schedule One drug. Simply put, in the eyes of federal law, cannabis is illegal. Is Medical Cannabis Legal? allow the use of medical cannabis.

Law 62

Law Chronic Pain Conditions Legislation 62

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

JUNE 11, 2021

In turn, here are the top 6 questions we’ve been getting lately around ketamine clinics: Isn’t the regulation of ketamine clinics just like adult-use/medicinal cannabis businesses? Pursuant to the federal Controlled Substances Act, cannabis is an illegal schedule I controlled substance while ketamine is on schedule III. No, it’s not.

Law 104

Law Compliance Compliance DEA 104

SpeedWeed

AUGUST 8, 2021

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . If all goes according to plan, patients will receive Sativex and the temozolomide chemotherapy drug, temozolomide on its own, or a placebo.

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

MedicalJane

JUNE 29, 2018

None of the approved drugs contain, or are derived from, the whole cannabis plant. The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. a Canada-based medical cannabis firm.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Veriheal

MAY 6, 2022

Millions of post-traumatic stress disorder (PTSD) patients around the world—such as ex-veterans and military servicemen—tend to relive their traumatic flashbacks and experiences during sleep. The good news is that cannabis could be the tool for a good night’s sleep. Conflicting Evidence on Cannabis and Sleep.

Sleep 98

Sleep Cannabinoids THC CBD 98

SpeedWeed

AUGUST 11, 2021

MAPS, The Multidisciplinary Association for Psychedelic Substances, was awarded a $12,979,050 million grant from the state of Michigan to fund a study on PTSD and cannabis on August 10. This grant enables more rigorous study, overseen by the FDA, which may lead to cannabis flower becoming prescribable medicine someday.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

AUGUST 18, 2022

Smith , a partner with the firm and co-leader of the firm’s Life Sciences & Health Effects Team, will lead the practice, bringing together scientist-attorneys and experienced litigators to support clients that are driving innovation in mental health treatments. Tweet this. However, change appears imminent.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. See Deborah Brauser, FDA Permits Psilocybin to Be Tested for Refractory Depression, MEDSCAPE (Oct.

Law 105

Law Therapy Clinical Trials Research and Development 105

The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. It was also after the Vietnam War that widespread ketamine abuse would begin to show up as a party drug. 9 How is ketamine commonly used?

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

CannaMD

NOVEMBER 20, 2020

a wealth of new research legitimizing marijuana’s role in patient care – here we are. Making matters worse, there’s only one farm in the entire country with DEA approval to cultivate marijuana for research purposes. Cannabis vs. Opioids. For more details, see: Best Cannabis Disorder Treatment? More Cannabis.

Therapy 80

Therapy Treatment DEA CBD 80

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. Therefore, it no longer meets the criteria for placement in Schedule I. While … Keep reading.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

CannaMD

MAY 6, 2020

However, given rapidly evolving – and often complicated – laws surrounding medical marijuana, many patients feel overwhelmed. Just like using medical marijuana in residential apartments , traveling with cannabis comes down to federal versus state law. For more information, see: The California Cannabis Portal. CALIFORNIA.

Hash 103

Hash Legalization Marijuana Concentrates 103

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

The Blunt Truth

OCTOBER 3, 2019

Plus, a new bill would legalize cannabis with state-run stores. In Minnesota , lawmakers are conducting “Be Heard on Cannabis” discussions, so that citizens can share their views on legal marijuana. Also in New Mexico , growers of medical cannabis are suing the state over limits on plant-count.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” Mitchell et al., Divito & Robert F. TIMES (Nov. 10, 2019), [link] [ [link] ]. Feduccia et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Veriheal

JUNE 29, 2021

This Act permits individuals that have been diagnosed with life-threatening conditions or diseases that have exhausted all other approved treatment and therapeutic options that are also unable to participate in clinical trials the ability to access certain treatments that would otherwise be unapproved for access. A Push by Patients.

Therapy 64

Therapy DEA Patients Clinical Trials 64

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. Commercial Operations. Traditionally Regulated Medical Practice.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Alchimia

APRIL 17, 2018

As research on the different cannabinoids and terpenes – and other compounds produced by the cannabis plant – advances, more and more testimonies claim that the efficacy of these substances is beyond doubt. Cannabis can help our pets to have a healthier life. Cannabis and your dog can become great friends.

Pets 75

Pets CBD Cannabinoids Terpenes 75

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. One group self-administered cannabis with 12% THC over three weeks.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

SEPTEMBER 23, 2021

Tracking recent data from within the last year (following the publication of the DEA Interim Final Rule which added confusion to the delta-8 legality question), more than a dozen hospital or emergency room visits and hundreds of calls to poison control were reported. Delta-8 THC products should be kept out of the reach of children and pets.

THC 52

THC Concentrates Pets DEA 52

Canna Law Blog

SEPTEMBER 28, 2019

We’ve written a lot about cannabis and the Controlled Substances Act. Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. From immigration to waste dumping. The ruling is Albuquerque Public Schools v.

Education 60

Education Oil DEA Cannabis 60

Cannabis Law Report

SEPTEMBER 20, 2019

They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. DEA increases the cannabis research quota. Battle heating up over Florida ballot initiative to legalize cannabis for adult use.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Cannabis became legal for recreational use in the state on Jan. But do medical cannabinoids actually help animal patients? Earlier this year, Gov. 1, 2017, following a 2016 ballot measure.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. They are responsible for giving you information about the treatment and proper use. Other states have a list of conditions that the patients must meet to get an MMJ. The DEA does not know who has MMJs and no consolidated database exists.

Marijuana 52

Marijuana Patients Conditions Programs 52